Technology

Haemequine a Natural Support in the Fight Against EIPH (Bleeding)

Haemequine was created to offer a natural, holistic approach to supporting horses affected by EIPH. With consistent use since 1995, Haemequine has achieved an over 85% success rate in supporting horses prone to bleeding.

Our Approach 

Haemequine was formulated using carefully selected natural ingredients designed to work in harmony with the horse’s body.

The formulation was developed with these key goals:

  • Easy for the body to absorb
  • No risk of toxicity
  • Safe for use on race day
  • No prohibited substances
  • Suitable for international competition

This means Haemequine can be used confidently without regulatory concerns.

Early Success and Development

The first documented success occurred in Kentucky, USA, in 1995.

Two high-value mares that had failed all conventional treatments were given Haemequine. After just 17 days of use, both horses returned to racing and won without bleeding.

Word quickly spread among trainers, and further testing began.

The name Haemequine comes from the medical terms hemoglobin and hematopoietic, reflecting its focus on blood health and natural support.

Information icon

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.